Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival.
Maxime JullienAmandine Le BourgeoisPierre PeterlinAlice GarnierThierry GuillaumeMarie Christine BenePatrice ChevallierPublished in: Bone marrow transplantation (2023)
Keyphrases
- free survival
- peripheral blood
- allogeneic hematopoietic stem cell transplantation
- liver failure
- acute myeloid leukemia
- acute lymphoblastic leukemia
- stem cell transplantation
- respiratory failure
- drug induced
- aortic dissection
- bone marrow
- high dose
- hepatitis b virus
- intensive care unit
- low dose
- acute respiratory distress syndrome